Women's Ischemia Syndrome Evaluation (WISE) Pre-HFpEF
Women's Ischemia Syndrome Evaluation (WISE) Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure With Preserved Ejection Fraction (HFpEF)
Sponsor: Cedars-Sinai Medical Center
A observational or N/A phase clinical study on Coronary Microvascular Dysfunction and Heart Failure With Preserved Ejection Fraction (HFpEF), this trial is actively recruiting participants. The trial is conducted by Cedars-Sinai Medical Center and has accumulated 13 data snapshots since 2019. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
13 versions recorded-
Aug 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Aug 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2024 — Jul 2024 [monthly]
Recruiting
-
Dec 2022 — Mar 2024 [monthly]
Recruiting
▶ Show 8 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Aug 2020 — Nov 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Aug 2020 [monthly]
Not Yet Recruiting
-
Jul 2019 — Aug 2019 [monthly]
Not Yet Recruiting
-
Apr 2019 — Jul 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cedars-Sinai Medical Center
- University of Florida
For direct contact, visit the study record on ClinicalTrials.gov .